Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Eli Lilly and Company, 3 years.
Eli Lilly and Company
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 10, 2025 | T. Rowe Price Group Inc. | Shares withheld for tax | −2,855 | $105.37 | $300,831 |
| Dec 10, 2025 | T. Rowe Price Group Inc. | Grant or award | +244 | $100.42 | $24,473 |
| Nov 17, 2025 | Eli Lilly and Company | Grant or award | +215 | $1,021.70 | $220,003 |
| May 2, 2025 | T. Rowe Price Group Inc. | Grant or award | +186 | $101.07 | $18,840 |
| May 2, 2025 | T. Rowe Price Group Inc. | Shares withheld for tax | −600 | $88.12 | $52,872 |
| Dec 16, 2024 | Eli Lilly and Company | Grant or award | +12 | $779.00 | $9,667 |
| Dec 10, 2024 | T. Rowe Price Group Inc. | Shares withheld for tax | −1,617 | $123.59 | $199,845 |
| Dec 4, 2024 | T. Rowe Price Group Inc. | Grant or award | +15,448 | — | — |
| Dec 4, 2024 | T. Rowe Price Group Inc. | Grant or award | +213 | $113.18 | $24,129 |
| Nov 18, 2024 | Eli Lilly and Company | Grant or award | +13 | $727.20 | $9,664 |
| Nov 18, 2024 | Eli Lilly and Company | Grant or award | +303 | $727.20 | $220,000 |
| Oct 21, 2024 | Eli Lilly and Company | Grant or award | +11 | $906.13 | $9,967 |
| Sep 16, 2024 | Eli Lilly and Company | Grant or award | +10 | $923.54 | $9,235 |
| Aug 19, 2024 | Eli Lilly and Company | Grant or award | +10 | $921.81 | $9,218 |
| Jul 15, 2024 | Eli Lilly and Company | Grant or award | +10 | $950.46 | $9,505 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.